ID   CDK13_HUMAN             Reviewed;        1512 AA.
AC   Q14004; Q6DKQ9; Q75MH4; Q75MH5; Q96JN4; Q9H4A0; Q9H4A1; Q9UDR4;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 2.
DT   05-OCT-2010, entry version 105.
DE   RecName: Full=Cell division protein kinase 13;
DE            EC=2.7.11.22;
DE   AltName: Full=CDC2-related protein kinase 5;
DE   AltName: Full=Cell division cycle 2-like protein kinase 5;
DE   AltName: Full=Cholinesterase-related cell division controller;
GN   Name=CDK13; Synonyms=CDC2L, CDC2L5, CHED, KIAA1791;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANTS LEU-700
RP   AND MET-1170.
RC   TISSUE=Placenta;
RX   PubMed=11162436; DOI=10.1006/bbrc.2000.4042;
RA   Marques F., Moreau J.L., Peaucellier G., Lozano J.C., Schatt P.,
RA   Picard A., Callebaut I., Perre E., Geneviere A.M.;
RT   "A new subfamily of high molecular mass CDC2-related kinases with
RT   PITAI/VRE.";
RL   Biochem. Biophys. Res. Commun. 279:832-837(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ALA-356; PHE-403;
RP   GLN-410; ALA-500; GLY-624 AND MET-1062.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22737999; PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 361-1078, AND VARIANT LEU-700.
RC   TISSUE=Glioblastoma;
RX   MEDLINE=92115704; PubMed=1731328; DOI=10.1073/pnas.89.2.579;
RA   Lapidot-Lifson Y., Patinkin D., Prody C.A., Ehrlich G., Seidman S.,
RA   Ben-Aziz R., Benseler F., Eckstein F., Zakut H., Soreq H.;
RT   "Cloning and antisense oligodeoxynucleotide inhibition of a human
RT   homolog of cdc2 required in hematopoiesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:579-583(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 860-1512 (ISOFORM 1).
RC   TISSUE=Brain;
RX   MEDLINE=21245130; PubMed=11347906; DOI=10.1093/dnares/8.2.85;
RA   Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 8:85-95(2001).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-437 AND THR-442, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-317; SER-340; SER-342;
RP   SER-367 AND SER-383, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-317; SER-325;
RP   SER-437; SER-439 AND THR-1246, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-437 AND SER-441, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1066, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1054, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-317; SER-325;
RP   SER-358; SER-360; SER-383; SER-395; SER-397; SER-400; SER-437;
RP   SER-439; SER-525; SER-664; THR-871; THR-1056 AND THR-1246, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-317; SER-325;
RP   SER-340; SER-342; SER-349; SER-383; SER-395; SER-397; SER-400;
RP   SER-437; SER-439; THR-871 AND THR-1246, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383 AND THR-494, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-238; SER-315;
RP   SER-317; SER-325; SER-342; SER-348; SER-358; SER-360; SER-383;
RP   SER-385; SER-395; SER-397; SER-413; SER-436; SER-437; SER-439;
RP   SER-490; THR-492; SER-525; SER-527; SER-662; SER-664; SER-863;
RP   TYR-870; THR-871; SER-1048; SER-1054; THR-1058; THR-1143; SER-1146;
RP   THR-1147 AND THR-1246, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383 AND SER-437, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-556, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] ALA-494; ALA-500; ARG-670 AND
RP   MET-1170.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May be a controller of the mitotic cell cycle. Involved
CC       in the blood cell development.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14004-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14004-2; Sequence=VSP_013579;
CC   -!- TISSUE SPECIFICITY: Expressed in fetal brain, liver, muscle and in
CC       adult brain. Also expressed in neuroblastoma and glioblastoma
CC       tumors.
CC   -!- PTM: Phosphorylated upon DNA damage, probably by ATM or ATR.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA58424.1; Type=Frameshift; Positions=1006;
CC       Sequence=AAS07490.1; Type=Erroneous gene model prediction;
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdc2l5/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ297709; CAC10400.1; -; mRNA.
DR   EMBL; AJ297710; CAC10401.1; -; mRNA.
DR   EMBL; AY679523; AAT74623.1; -; Genomic_DNA.
DR   EMBL; AC072061; AAS07490.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC072061; AAS07491.1; -; Genomic_DNA.
DR   EMBL; AC006023; AAD54514.1; -; Genomic_DNA.
DR   EMBL; M80629; AAA58424.1; ALT_SEQ; mRNA.
DR   EMBL; AB058694; BAB47420.1; -; mRNA.
DR   IPI; IPI00029162; -.
DR   IPI; IPI00456970; -.
DR   PIR; A38197; A38197.
DR   RefSeq; NP_003709.3; -.
DR   RefSeq; NP_112557.2; -.
DR   UniGene; Hs.233552; -.
DR   ProteinModelPortal; Q14004; -.
DR   SMR; Q14004; 702-1001.
DR   MINT; MINT-1197921; -.
DR   STRING; Q14004; -.
DR   PhosphoSite; Q14004; -.
DR   PRIDE; Q14004; -.
DR   Ensembl; ENST00000181839; ENSP00000181839; ENSG00000065883.
DR   GeneID; 8621; -.
DR   KEGG; hsa:8621; -.
DR   NMPDR; fig|9606.3.peg.28511; -.
DR   UCSC; uc003thh.2; human.
DR   UCSC; uc003thi.2; human.
DR   CTD; 8621; -.
DR   GeneCards; GC07P039957; -.
DR   H-InvDB; HIX0006620; -.
DR   HGNC; HGNC:1733; CDK13.
DR   MIM; 603309; gene.
DR   PharmGKB; PA26264; -.
DR   eggNOG; prNOG12381; -.
DR   HOVERGEN; HBG050851; -.
DR   InParanoid; Q14004; -.
DR   OMA; RHSHSGE; -.
DR   OrthoDB; EOG9MGVSS; -.
DR   PhylomeDB; Q14004; -.
DR   BRENDA; 2.7.11.22; 247.
DR   NextBio; 32303; -.
DR   PMAP-CutDB; Q14004; -.
DR   ArrayExpress; Q14004; -.
DR   Bgee; Q14004; -.
DR   CleanEx; HS_CDC2L5; -.
DR   Genevestigator; Q14004; -.
DR   GermOnline; ENSG00000065883; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein kinase activity; IEA:EC.
DR   GO; GO:0007275; P:multicellular organismal development; TAS:ProtInc.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007088; P:regulation of mitosis; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1512       Cell division protein kinase 13.
FT                                /FTId=PRO_0000085711.
FT   DOMAIN      705    998       Protein kinase.
FT   NP_BIND     711    719       ATP (By similarity).
FT   ACT_SITE    837    837       Proton acceptor (By similarity).
FT   BINDING     734    734       ATP (By similarity).
FT   MOD_RES       3      3       Phosphoserine.
FT   MOD_RES     238    238       Phosphoserine.
FT   MOD_RES     315    315       Phosphoserine.
FT   MOD_RES     317    317       Phosphoserine.
FT   MOD_RES     325    325       Phosphoserine.
FT   MOD_RES     340    340       Phosphoserine.
FT   MOD_RES     342    342       Phosphoserine.
FT   MOD_RES     348    348       Phosphoserine.
FT   MOD_RES     349    349       Phosphoserine.
FT   MOD_RES     358    358       Phosphoserine.
FT   MOD_RES     360    360       Phosphoserine.
FT   MOD_RES     367    367       Phosphoserine.
FT   MOD_RES     383    383       Phosphoserine.
FT   MOD_RES     385    385       Phosphoserine.
FT   MOD_RES     395    395       Phosphoserine.
FT   MOD_RES     397    397       Phosphoserine.
FT   MOD_RES     400    400       Phosphoserine.
FT   MOD_RES     409    409       Phosphoserine (By similarity).
FT   MOD_RES     413    413       Phosphoserine.
FT   MOD_RES     436    436       Phosphoserine.
FT   MOD_RES     437    437       Phosphoserine.
FT   MOD_RES     439    439       Phosphoserine.
FT   MOD_RES     441    441       Phosphoserine.
FT   MOD_RES     442    442       Phosphothreonine.
FT   MOD_RES     490    490       Phosphoserine.
FT   MOD_RES     492    492       Phosphothreonine.
FT   MOD_RES     494    494       Phosphothreonine.
FT   MOD_RES     525    525       Phosphoserine.
FT   MOD_RES     527    527       Phosphoserine.
FT   MOD_RES     556    556       N6-acetyllysine.
FT   MOD_RES     662    662       Phosphoserine.
FT   MOD_RES     664    664       Phosphoserine.
FT   MOD_RES     863    863       Phosphoserine.
FT   MOD_RES     870    870       Phosphotyrosine.
FT   MOD_RES     871    871       Phosphothreonine.
FT   MOD_RES    1048   1048       Phosphoserine.
FT   MOD_RES    1054   1054       Phosphoserine.
FT   MOD_RES    1056   1056       Phosphothreonine.
FT   MOD_RES    1058   1058       Phosphothreonine.
FT   MOD_RES    1066   1066       Phosphoserine.
FT   MOD_RES    1143   1143       Phosphothreonine.
FT   MOD_RES    1146   1146       Phosphoserine.
FT   MOD_RES    1147   1147       Phosphothreonine.
FT   MOD_RES    1246   1246       Phosphothreonine.
FT   VAR_SEQ    1079   1138       Missing (in isoform 2).
FT                                /FTId=VSP_013579.
FT   VARIANT     340    340       S -> F (in dbSNP:rs13622).
FT                                /FTId=VAR_053926.
FT   VARIANT     356    356       P -> A (in dbSNP:rs17537669).
FT                                /FTId=VAR_022381.
FT   VARIANT     403    403       L -> F (in dbSNP:rs3735137).
FT                                /FTId=VAR_022382.
FT   VARIANT     410    410       R -> Q (in dbSNP:rs17496261).
FT                                /FTId=VAR_022383.
FT   VARIANT     494    494       T -> A (in dbSNP:rs34624759).
FT                                /FTId=VAR_041965.
FT   VARIANT     500    500       T -> A (in dbSNP:rs3735135).
FT                                /FTId=VAR_022384.
FT   VARIANT     624    624       S -> G (in dbSNP:rs17496275).
FT                                /FTId=VAR_022385.
FT   VARIANT     670    670       T -> R (in dbSNP:rs34775357).
FT                                /FTId=VAR_041966.
FT   VARIANT     700    700       R -> L (in dbSNP:rs1057000).
FT                                /FTId=VAR_022386.
FT   VARIANT    1062   1062       V -> M (in dbSNP:rs17496712).
FT                                /FTId=VAR_022387.
FT   VARIANT    1170   1170       V -> M (in dbSNP:rs3204309).
FT                                /FTId=VAR_041967.
FT   CONFLICT     21     21       K -> R (in Ref. 1; CAC10400/CAC10401).
FT   CONFLICT    671    671       A -> T (in Ref. 1 and 4).
FT   CONFLICT    810    810       N -> Y (in Ref. 4; AAA58424).
FT   CONFLICT    862    866       YSSEE -> FSVFF (in Ref. 5; BAB47420).
FT   CONFLICT   1035   1035       Missing (in Ref. 4).
SQ   SEQUENCE   1512 AA;  164923 MW;  3CA54A3585A2943D CRC64;
     MPSSSDTALG GGGGLSWAEK KLEERRKRRR FLSPQQPPLL LPLLQPQLLQ PPPPPPPLLF
     LAAPGTAAAA AAAAAASSSC FSPGPPLEVK RLARGKRRAG GRQKRRRGPR AGQEAEKRRV
     FSLPQPQQDG GGGASSGGGV TPLVEYEDVS SQSEQGLLLG GASAATAATA AGGTGGSGGS
     PASSSGTQRR GEGSERRPRR DRRSSSGRSK ERHREHRRRD GQRGGSEASK SRSRHSHSGE
     ERAEVAKSGS SSSSGGRRKS ASATSSSSSS RKDRDSKAHR SRTKSSKEPP SAYKEPPKAY
     REDKTEPKAY RRRRSLSPLG GRDDSPVSHR ASQSLRSRKS PSPAGGGSSP YSRRLPRSPS
     PYSRRRSPSY SRHSSYERGG DVSPSPYSSS SWRRSRSPYS PVLRRSGKSR SRSPYSSRHS
     RSRSRHRLSR SRSRHSSISP STLTLKSSLA AELNKNKKAR AAEAARAAEA AKAAEATKAA
     EAAAKAAKAS NTSTPTKGNT ETSASASQTN HVKDVKKIKI EHAPSPSSGG TLKNDKAKTK
     PPLQVTKVEN NLIVDKATKK AVIVGKESKS AATKEESVSL KEKTKPLTPS IGAKEKEQHV
     ALVTSTLPPL PLPPMLPEDK EADSLRGNIS VKAVKKEVEK KLRCLLADLP LPPELPGGDD
     LSKSPEEKKT ATQLHSKRRP KICGPRYGET KEKDIDWGKR CVDKFDIIGI IGEGTYGQVY
     KARDKDTGEM VALKKVRLDN EKEGFPITAI REIKILRQLT HQSIINMKEI VTDKEDALDF
     KKDKGAFYLV FEYMDHDLMG LLESGLVHFN ENHIKSFMRQ LMEGLDYCHK KNFLHRDIKC
     SNILLNNRGQ IKLADFGLAR LYSSEESRPY TNKVITLWYR PPELLLGEER YTPAIDVWSC
     GCILGELFTK KPIFQANQEL AQLELISRIC GSPCPAVWPD VIKLPYFNTM KPKKQYRRKL
     REEFVFIPAA ALDLFDYMLA LDPSKRCTAE QALQCEFLRD VEPSKMPPPD LPLWQDCHEL
     WSKKRRRQKQ MGMTDDVSTI KAPRKDLSLG LDDSRTNTPQ GVLPSSQLKS QGSSNVAPVK
     TGPGQHLNHS ELAILLNLLQ SKTSVNMADF VQVLNIKVNS ETQQQLNKIN LPAGILATGE
     KQTDPSTPQQ ESSKPLGGIQ PSSQTIQPKV ETDAAQAAVQ SAFAVLLTQL IKAQQSKQKD
     VLLEERENGS GHEASLQLRP PPEPSTPVSG QDDLIQHQDM RILELTPEPD RPRILPPDQR
     PPEPPEPPPV TEEDLDYRTE NQHVPTTSSS LTDPHAGVKA ALLQLLAQHQ PQDDPKREGG
     IDYQAGDTYV STSDYKDNFG SSSFSSAPYV SNDGLGSSSA PPLERRSFIG NSDIQSLDNY
     STASSHSGGP PQPSAFSESF PSSVAGYGDI YLNAGPMLFS GDKDHRFEYS HGPIAVLANS
     SDPSTGPEST HPLPAKMHNY NYGGNLQENP SGPSLMHGQT WTSPAQGPGY SQGYRGHIST
     STGRGRGRGL PY
//
